InfuSystem Holdings (INFU) EBT Margin (2010 - 2026)
InfuSystem Holdings (INFU) posted EBT Margin of 4.21% for Q1 2026, down 56.74% on a QoQ basis from 9.72% in Q4 2025, and up 334.0% year-over-year from 0.97% in Q1 2025.
InfuSystem Holdings (INFU) EBT Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings' EBT Margin history runs 17 years deep, the most recent figure standing at 4.21% for Q1 2026.
- Quarterly EBT Margin rose 334.0% year-over-year to 4.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.26% (up 343.0% YoY) and the FY2025 annual result came in at 7.41%, up 365.0% from the prior year.
- EBT Margin was 4.21% for Q1 2026 at InfuSystem Holdings, down from 9.72% in the prior quarter.
- Across five years, EBT Margin topped out at 9.72% in Q4 2025 and bottomed at 4.06% in Q1 2024.
- A 5-year average of 3.19% and a median of 2.36% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin tumbled 507 bps — and 2025, when it soared 559 bps.
- InfuSystem Holdings' EBT Margin stood at 1.91% in 2022, then increased by 24 bps to 2.36% in 2023, then jumped by 182 bps to 6.67% in 2024, then soared by 46 bps to 9.72% in 2025, then plunged by 57 bps to 4.21% in 2026.
- Business Quant data shows INFU's EBT Margin at 4.21% in Q1 2026, 9.72% in Q4 2025, and 9.39% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 4.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.21% |
| Dec 31, 2025 | 9.72% |
| Sep 30, 2025 | 9.39% |
| Jun 30, 2025 | 9.44% |
| Mar 31, 2025 | 0.86% |
| Dec 31, 2024 | 6.67% |
| Sep 30, 2024 | 7.89% |
| Jun 30, 2024 | 3.86% |
| Mar 31, 2024 | -4.06% |
| Dec 31, 2023 | 2.36% |
| Sep 30, 2023 | 3.51% |
| Jun 30, 2023 | 1.99% |
| Mar 31, 2023 | -1.98% |
| Dec 31, 2022 | 1.91% |
| Sep 30, 2022 | 2.01% |
| Jun 30, 2022 | -0.51% |
| Mar 31, 2022 | -3.10% |
| Dec 31, 2021 | 4.14% |
| Sep 30, 2021 | -2.50% |
| Jun 30, 2021 | 1.38% |